Colon Cancer Community Weighs “Master Protocol” Approach
Executive Summary
Building on enthusiasm for the multi-sponsor, multi-drug clinical trial due to get underway in lung cancer soon, stakeholders in academia, industry, government and the patient community have begun discussions about a similar, biomarker-driven trial in colon cancer.